# CanadaBuys #SN26003

PMPRB Subscription to Global Drug Pricing and Reimbursement Intelligence

**Posted:** October 22, 2026
**Respond By:** November 06, 2026
**Identifier:** SN26003
**NAICS:** 541990

The Government of Canada’s PMPRB seeks a subscription to global pharmaceutical pricing and reimbursement intelligence services.
- **Government buyer:** Government of Canada, Patented Medicine Prices Review Board (PMPRB/CEPMB); no specific office is identified.
- **Named supplier:** **GlobalData Publications Inc.** is identified as the pre-selected supplier. No other vendors are named in the provided material.
- **Requested service:** One subscription to an integrated drug pricing and reimbursement intelligence platform with supporting research and analyst services; no product part number is provided.
  - Global hospital and retail drug prices, historical price data, and treatment-cost information, including at least 10 years of historical data where available.
  - Therapeutic cost analysis and calculation tools, plus pricing and reimbursement news, policy information, country reports, and market-access risk scores.
  - International reference-pricing analysis covering more than 60 referring markets and 80 reference markets.
  - Access for up to 15 PMPRB users, multilingual analyst support, real-time updates and alerts, standardized reference-pricing spreadsheets, and Excel exports of at least 3,000 rows.
  - Required data and platform access must be available within 30 days of award and continue through the contract period.
- **Period of performance:** An initial period of about one year, with four additional one-year options, for up to five years total. The notice materials also describe a 60-month duration.
- **Estimated value:** USD 392,981 before applicable taxes, including options.

### Description

The Patented Medicine Prices Review Board (PMPRB) seeks access to an integrated platform and supporting services providing comprehensive, structured, regularly updated international pharmaceutical pricing and reimbursement information, analytics, and intelligence. The requirements include global drug price data and history, therapeutic cost analysis, pricing and reimbursement market intelligence, and international reference pricing information. The service must provide access for up to 15 PMPRB users, data exports to Excel, and real-time updates, with all requirements available within 30 days of contract award. The proposed contract is for an initial period from March 1, 2027 to March 31, 2028, with four one-year options; the notice identifies GlobalData Publications Inc. as the pre-identified supplier.

[View original listing](https://canadabuys.canada.ca/en/tender-opportunities/tender-notice/cb-219-49543150)